» Articles » PMID: 15239098

Bile Acid-induced Negative Feedback Regulation of the Human Ileal Bile Acid Transporter

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2004 Jul 9
PMID 15239098
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

Ileal expression of the apical sodium-dependent bile acid transporter (ASBT) in the rat is unaffected by bile salts, yet in the mouse it is under negative-feedback regulation. The bile acid responsiveness of human ASBT is unknown. The human ASBT promoter linked to a luciferase reporter was studied in Caco-2 cells treated with chenodeoxycholic acid (CDCA) and transfected with expression plasmids for farnesoid X-receptor (FXR), short heterodimer partner (SHP), and retinoic acid receptor/retinoid X receptor (RAR/RXR). CDCA treatment of Caco-2 cells led to a 75% reduction in steady-state ASBT messenger RNA levels and a 78% reduction in human ASBT promoter activity. A dominant negative FXR abrogated the response to CDCA. Site-directed mutagenesis of an RAR/RXR cis element in the human ASBT promoter reduced its activity by 50% and eliminated the bile acid response. Retinoic acid activated the human ASBT promoter fourfold. SHP repressed the activity of the ASBT promoter and reduced activation by retinoic acid. Antisense mediated knock-down of SHP in Caco-2 cells partially offset the bile acid mediated repression of ASBT promoter activity. In conclusion, the human ASBT is positively regulated by retinoic acid. Bile acids induce a negative feedback regulation of human ASBT via an FXR-mediated, SHP-dependent effect upon RAR/RXR activation of ASBT.

Citing Articles

Host response to cholestyramine can be mediated by the gut microbiota.

Newman N, Monnier P, Rodrigues R, Gurung M, Vasquez-Perez S, Hioki K Microbiome Res Rep. 2025; 3(4):40.

PMID: 39741955 PMC: 11684918. DOI: 10.20517/mrr.2023.82.


Novel Expression of Apical Bile Acid Transport (ASBT) More Proximally Than Distal Ileum Contributing to Enhanced Intestinal Bile Acid Absorption in Obesity.

Sundaram S, Jagadeesan A, Paulraj R, Sundaram U, Arthur S Int J Mol Sci. 2024; 25(21).

PMID: 39519005 PMC: 11547122. DOI: 10.3390/ijms252111452.


Retinoid X receptor heterodimers in hepatic function: structural insights and therapeutic potential.

Xu R, Zhang L, Pan H, Zhang Y Front Pharmacol. 2024; 15:1464655.

PMID: 39478961 PMC: 11521896. DOI: 10.3389/fphar.2024.1464655.


The role of botanical triterpenoids and steroids in bile acid metabolism, transport, and signaling: Pharmacological and toxicological implications.

Luo Z, Zhou W, Xie T, Xu W, Shi C, Xiao Z Acta Pharm Sin B. 2024; 14(8):3385-3415.

PMID: 39220868 PMC: 11365449. DOI: 10.1016/j.apsb.2024.04.027.


The gut microbiota-bile acid axis in cholestatic liver disease.

Sun D, Xie C, Zhao Y, Liao J, Li S, Zhang Y Mol Med. 2024; 30(1):104.

PMID: 39030473 PMC: 11265038. DOI: 10.1186/s10020-024-00830-x.